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 West Nile virus (WNV) outbreaks in North America have 
been characterized by substantial die-offs of American 
crows (Corvus brachyrhynchos). In contrast, a low inci-
dence of bird deaths has been observed during WNV epi-
demic activity in Europe. To examine the susceptibility of the 
western European counterpart of American crows, we inoc-
ulated carrion crows (Corvus corone) with WNV strains iso-
lated in Greece (Gr-10), Italy (FIN and Ita09), and Hungary 
(578/10) and with the highly virulent North American geno-
type strain (NY99). We also inoculated American crows with 
a selection of these strains to examine the strains’ virulence 
in a highly susceptible bird species. Infection with all strains, 
except WNV FIN, resulted in high rates of death and high-
level viremia in both bird species and virus dissemination 
to several organs. These results suggest that carrion crows 
are highly susceptible to WNV and may potentially be useful 
as part of dead bird surveillance for early warning of WNV 
activity in Europe.
West Nile virus (WNV), a flavivirus (family Flavi-viridae) transmitted by mosquitoes, uses birds as its 
primary vertebrate reservoir host. WNV has an extensive 
geographic range that includes Europe, Africa, the Mid-
dle East, southern Asia, and Australia (1). In 1999, WNV 
emerged in North America, where it was first detected in 
New York, New York. The virus subsequently spread rap-
idly across the continent, becoming the leading cause of 
arboviral encephalitis in humans and horses (2), and it was 
associated with deaths among at least 326 bird species 
(3). High death rates are most frequently observed among 
passeriform birds, of which the family Corvidae comprises 
the most highly susceptible species to WNV (4). In particu-
lar, deaths among the American crow (Corvus brachyrhyn-
chos) have been used to track the spread of the virus across 
many parts of North America (5–8).
Since 2008, WNV has been responsible for outbreaks 
throughout central and southeastern Europe, affecting 
countries such as Greece, Italy, Hungary, Romania, and 
Croatia and constituting a serious veterinary and public 
health problem. Fatalities have been reported among wild 
birds in Europe, such as eagles (9,10), sparrow hawks, gos-
hawks, geese, and falcons (11–13). However, death rates 
among birds in Europe have been low, and no clustered 
death events have occurred, even when cases were asso-
ciated with outbreaks of severe human and equine WNV 
infections (14–17). Several theories have been proposed to 
explain the low death rates among birds in Europe: limited 
or insufficient monitoring of deaths among wild birds in 
Europe; development of immunity among birds from infec-
tions acquired on wintering grounds (18); and circulation 
of WNV strains in Europe with reduced virulence for birds.
Experimental infection of American crows with the 
North American genotype of WNV (NY99) has shown that 
the strain has a highly pathogenic phenotype: viremia titers 
exceeded 9 log10 PFU/mL, and all infected birds died (19–
23). However, the lack of WNV-associated bird deaths in 
Europe suggests that European birds might not be suscep-
tible to WNV or that WNV strains from Europe are not vir-
ulent to birds. Thus, we evaluated the susceptibility of the 
European equivalent of the American crow, carrion crows 
(Corvus corone), which are ubiquitously present across Eu-
rope, by injecting them with selected strains of WNV cir-
culating in Europe and with the prototypic NY99 strain. In 
addition, we inoculated American crows with a selection of 
these viruses to assess and compare the virulence of WNV 
strains from Europe in a bird species known to be highly 
susceptible to WNV. Susceptibility was assessed in terms 
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of death, survival time, magnitude and duration of viremia, 
and spread of virus to different organs.
Materials and Methods
Source of Virus and Birds
Five different WNV strains were used in this study: lineage 
1a strain NY99-4132 (NY-99) (20); lineage 2 strain Nea 
Santa-Greece-2010 (Greece-10; GenBank accession no. 
HQ537483.1) (24); lineage 1a strain Italy/2009/FIN (FIN; 
GenBank accession no. KF234080); lineage 1a strain Ita09 
(GenBank accession no. GU011992.2) (25); and lineage 2 
strain 578/10 (GenBank accession no. KC496015). Further 
details about these viruses are provided in Table 1.
Carrion crows were captured by using walk-in traps in 
the municipality of Rotterdam, the Netherlands, and then 
transported to indoor housing at the animal holding facili-
ties at the National Institute for Public Health and the En-
vironment, Bilthoven, the Netherlands. After being inocu-
lated with WNV, the crows were cared for in groups of 8 in 
isolators under negative pressure. Only seronegative birds 
were used in this study. Seronegativity was determined 
by using a neutralization assay (online Technical Ap-
pendix, http://wwwnc.cdc.gov/EID/article/21/8/14-0714-
Techapp1.pdf).
American crows were captured by using cannon net 
traps in Bellvue, Colorado, USA; the National Wildlife 
Diseases Program, Animal and Plant Health Inspection 
Service, United States Department of Agriculture, assisted 
with the captures. The crows were banded and transported 
to Fort Collins, Colorado, where they were housed in 1-m3 
cages (2 birds per cage) at the Colorado State University 
Animal Disease Laboratory.
Experimental Infection and Sampling Protocol
Crows were subcutaneously inoculated in the thigh or 
breast region with 2,000 50% tissue culture infectious dos-
es (TCID50) of virus per 0.1 mL of serum-free Dulbecco’s 
Modified Eagle Medium (DMEM) (Lonza Benelux BV, 
Breda, the Netherlands). Carrion crows (8 per virus) were 
injected with WNV strain NY99, Greece-10, FIN, Ita09, or 
578/10. American crows were inoculated with NY99 (n = 
6), FIN (n = 5), or Ita09 (n = 5). Approximately 0.1 mL of 
blood was collected from carrion crows at 2-day intervals, 
up to 8 days postinoculation (dpi), and 0.2 mL of blood 
was collected from American crows at the same time points 
and added to 0.9 mL of serum-free DMEM. Coagulated 
blood from carrion crows was centrifuged at 1,300 × g for 
5 min in MiniCollect vials (Greiner Bio-One, Alphen aan 
den Rijn, the Netherlands) to separate serum, and coagu-
lated blood from American crows was centrifuged at 3,700 
× g for 10 min to pellet clotted cells. Serum samples were 
stored at −80°C until further use.
Crows were examined for clinical signs twice daily for 
14 dpi and euthanized under isoflurane anesthesia upon dis-
play of clinical signs. In addition, 2 birds per group of the 
carrion crows were euthanized at 4 dpi.
Necropsies were performed on all euthanized car-
rion crows; heart, liver, spleen, kidney, bone marrow, and 
brain samples were collected. A small section of each tis-
sue was collected, weighed, and homogenized by using a 
metal bead in 1 mL of DMEM containing 100 U penicillin 
and 100 µg/mL streptomycin. The remaining portion of the 
tissues was collected in formalin for use in immunohisto-
chemical staining.
Determination of Virus Loads
We used quantitative real-time reverse transcription PCR 
(qRT-PCR) to determine virus titers in serum and tissue 
samples and TCID50 titration to calculate infectious virus 
titers in serum only. In brief, RNA was isolated from 50 
μL of serum or 100 μL of homogenized tissue by using the 
MagNA Pure LC Total Nucleic Acid Isolation Kit (Roche, 
Almere, the Netherlands) and a MagNA Pure LC automat-
ed nucleic acid robotic workstation (Roche) according to 
the manufacturer’s instructions, and subsequently stored at 
−80°C. RNA copy numbers were quantified by using un-
modified primers as previously described (26). The limit of 
detection of the assay was 9 (1.0 log10) RNA copies.
After log10 titration of serum samples on Vero E6 cells, 
cytopathic effect was determined at 5 dpi and TCID50 infec-
tious titers were calculated by using the Spearman–Kärber 
method (27,28). An initial 1:10 dilution of serum resulted 
in a limit of detection of 101.8 TCID50/mL.
Immunohistochemistry
Paraffin sections (4-µm thick) of sagittal organ were pro-
cessed for streptavidin–biotin–peroxidase immunohisto-
chemical detection of nonstructural protein (NS) 3 anti-
gen. Sections were deparaffinized in xylene, rehydrated in 
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Table 1. West Nile virus strains used for susceptibility studies in carrion and American crows 
Strain Source 
Passage 
history* Location 
Genetic 
lineage 
Crow species 
inoculated 
NY99-4132 American crow (brain) V2 United States 1a Carrion, American 
Nea Santa-Greece-2010 Culex pipiens mosquito V1 Greece 2 Carrion 
Italy/2009/FIN Human with neuroinvasive disease V2, C1 Italy 1a Carrion, American 
Ita09 Human with neuroinvasive disease V1, C1 Italy 1a Carrion, American 
578/10 Horse (brain) V2, C1 Hungary 2 Carrion 
*Viruses were propagated in Vero (V) or C6/36 insect cells (C). Numbers following passage source represent the number of virus passages. 
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descending concentrations of ethanol, and incubated for 10 
min in 3% H2O2 diluted in PBS to block endogenous per-
oxidase activity. Antigen exposure was performed by in-
cubation at 121°C for 15 min in citrate buffer (10 mmol/L, 
pH 6.0). Sections were subsequently incubated overnight at 
4°C with polyclonal goat anti-WNV NS3 protease (1:100; 
R&D Systems, Abingdon, UK) or isotype control (goat se-
rum, 1:100; Dako, Eindhoven, the Netherlands) and then 
detected with polyclonal rabbit anti-goat IgG/HRP (Dako) 
antibody. Sections were counterstained with Mayer hema-
toxylin, mounted with Kaiser glycerin-gelatin, and ana-
lyzed by using a light microscope.
Statistical Analyses
Survival curves were analyzed by using the log-rank (Man-
tel-Cox) test. Statistical analyses between >2 groups were 
performed by using Kruskal-Wallis 1-way analysis of vari-
ance; any significant differences were more closely ana-
lyzed between the groups by using the Mann-Whitney U 
test. A Bonferroni correction was applied to each p value, 
according to the number of comparisons (corrected p value 
of 0.05/10 = 0.005 for carrion crow peak viremia and or-
gans of carrion crows euthanized on day 4; corrected p val-
ue of 0.05/6 = 0.008 for American crow peak viremia and 
organs of carrion crows euthanized due to illness). For all 
comparisons, each group had 6 crows, except for American 
crow groups that received FIN or Ita09 (n = 5).
Results
Illness and Death
Signs of illness (e.g., lethargy, unresponsiveness, anorexia, 
and ruffled feathers) were observed among most crows 
within 9 dpi. All 6 carrion crows inoculated with Greece-10 
or Ita09 died, and 5 (83%) of the 6 inoculated with NY99 or 
578/10 died. All 6 carrion crows inoculated with strain FIN 
survived (Table 2). Survival curves of the infected birds 
showed a significant difference in survival between carrion 
crows infected with Ita09, Greece-10, NY99, or 578/10 and 
those infected with FIN (p = 0.005) (Figure 1). The median 
day of death was 7 dpi for carrion crows that died from in-
fection with NY99, Greece-10, or Ita09 and 8 dpi for birds 
that died from infection with 578/10. All American crows 
inoculated with NY99 (n = 6) or Ita09 (n = 5) died, and all 
5 crows inoculated with FIN survived (Table 3).
Viremia Profiles
WNV viremia profiles were determined in terms of viral 
RNA (Table 2; Figure 2) and infectious virus titers in se-
rum (Table 2; Figure 3) of infected carrion crows. In strain 
NY99–infected birds, the median peak viral RNA titer was 
108.7 RNA copies/mL of serum (range 101–1010.0 [nontrans-
formed values]), and the median peak infectious virus ti-
ter was 107.4 TCID50/mL of serum (range 10
1.8–108.8); these 
values include 1 bird in which detectable viremia did not 
develop during the entire course of infection. The median 
peak viremia titer for Greece-10–infected birds was 1010.3 
RNA copies/mL of serum (range 109.8–1011.7) and 107.8 
TCID50/mL of serum (range 10
7.3–109.8). FIN-infected birds 
had median peak viremia titers of 102.7 RNA copies/mL 
of serum (range 101–105.9) and 101.8 TCID50/mL of serum 
(range 101.8–102.5); however, viremia was detectable in only 
3 of 6 birds, and infectious virus could be isolated from only 
1 bird. The median peak viremia titers for Ita09-infected 
birds were 109.7 RNA copies/mL of serum (range 108.0–
1010.0) and 107.6 TCID50/mL of serum (range 10
6.3–108.8). 
Birds infected with strain 578/10 had median peak viremia 
titers of 108.4 RNA copies/mL of serum (range 106.0–1010.1) 
and 105.1 TCID50/mL of serum (range 10
2.8–108.5).
Strain Greece-10–infected birds had median peak viral 
RNA titers significantly higher than those for NY99-infect-
ed (p = 0.004), FIN-infected (p = 0.005), and 578/10-in-
fected (p = 0.004) birds. Greece-10–infected birds also 
had median infectious virus titers significantly higher than 
those for FIN-infected birds (p = 0.003), but FIN-infected 
birds had RNA and infectious titers lower than those for 
Greece-10–infected (p = 0.005 and 0.003, respectively), 
Ita09-infected (p = 0.005 and 0.002, respectively), and 
578/10-infected (p = 0.005 and 0.002, respectively) crows.
Viremia profiles were also determined for American 
crows infected with 3 of the 5 different WNV strains (Table 
3). NY99-infected birds had median peak viremia titers of 
109.6 RNA copies/mL of serum (range 109.1–1010.1) and 107.2 
TCID50/mL of serum (range 10
4.7–107.2). Detectable viremia 
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Table 2. Clinical profile for carrion crows experimentally infected with various West Nile virus strains* 
Virus group 
No. died/no. 
total (%) 
Day of 
death, 
median dpi 
Median peak viremia, 
viral RNA/mL serum 
(range); no. birds 
Mean duration, d, 
of viremia  SD; no. 
birds† 
Mean day of peak 
viremia  SD; no. 
birds† 
Median peak 
viremia TCID50/mL 
(range); no. birds‡ 
NY99-4132 5/6 (83) 7 108.7 (101.0–1010.0); 6 5.2  1.0; 5 4.3  0.7; 5 107.4 (101.8–108.8); 6 
Nea Santa-
Greece-2010 
6/6 (100) 7 1010.3 (109.8–1011.7); 6 5.7  0.7; 6 4.5  0.9; 6 107.8 (107.3–109.8); 6 
Italy/2009/FIN 0/6 (0) NA 102.7 (101.0–105.9); 6 2.7  0.9; 3 6.7  0.9; 3 101.8 (101.8–102.5); 6 
Ita09 6/6 (100) 7 109.7 (108.0–1010.0); 6 6.0  1.2; 6 4.3  0.7; 6 107.6 (106.3–108.8); 6 
578/10 5/6 (83) 8 108.4 (106.0–1010.1); 6 5.7  1.8; 6 3.5  0.9; 6 105.1 (102.8–108.5); 6 
*dpi, days postinoculation; NA, not applicable; TCID50, 50% tissue culture infectious dose. 
†Based on viral RNA titers. 
‡Viral titers are expressed as log10 TCID50/mL of serum. 
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developed in only 2 of the 5 FIN-infected birds, resulting in 
median peak viremia titers of 101.0 RNA copies/mL of se-
rum (range 101–106.9) and 101.8 TCID50/mL of serum (range 
101.8–102.7). Median peak viremia titers for Ita09-infected 
birds were 108.8 RNA copies/mL of serum (range 108.0–109.1) 
and 106.7 TCID50/mL of serum (range 10
6.0–107.5). American 
crows infected with strain NY99 had the highest median peak 
viral RNA and infectious virus titers, and FIN-infected birds 
had the lowest median titers (significant only when com-
pared with each other: p = 0.008 and 0.006, respectively).
Tissue Tropism
Virus loads were determined in the heart, liver, spleen, 
kidney, bone marrow, and brain of all birds. To assess the 
spread of virus to the different organs at the approximate 
peak of viremia, we euthanized 2 birds per group at 4 dpi. 
Virus was detected in all organs from these birds. On aver-
age, the highest viral RNA titers were detected in the liver, 
followed by the bone marrow, spleen, kidney, and heart; 
the lowest titers were found in the brain (Figure 4). Be-
tween the different virus strains, viral RNA titers were the 
highest in the organs of birds infected with strain Greece-10 
or 578/10, followed by NY99 and Ita09; titers were signifi-
cantly higher than those for birds infected with strain FIN 
(p = 0.005 for all). Virus distribution in FIN-infected birds 
was not consistent; viral RNA was undetectable in the bone 
marrow and brain of both birds tested on 4 dpi, and for 1 of 
these birds, viral RNA was also undetectable in the spleen.
Birds euthanized because of illness had virus pres-
ent in all organs; in most cases, the spleen, liver, and bone 
marrow contained the highest average viral RNA load, 
followed by kidney and heart; the lowest average viral 
RNA titers were in the brain. Viral RNA titers in organs of 
Greece-10–infected birds were higher than those in organs 
of birds infected with the other viruses, but this observation 
was not statistically significant (Figure 5).
The 1 NY99-infected and 3 FIN-infected survivor 
birds that were free of viremia throughout the 8 days of 
blood sampling underwent necropsy at 14 dpi. Of interest, 
virus was present in all organs of the NY99-infected bird 
(median virus load of 103.1 RNA copies/g of tissue) and in 
at least 3 of the 6 organs from FIN-infected birds (median 
virus load of 102.0 RNA copies/g of tissue), showing that 
these birds did undergo productive WNV infection.
Immunohistochemistry
Sections of organs from 2 birds necropsied at 4 dpi were 
stained with polyclonal anti-WNV NS3 to confirm replica-
tion of virus in the tissues and to exclude positive qRT-
PCR detection due to spillover from blood at the approxi-
mate peak of viremia. Tissues most consistently positive 
for WNV antigen were the liver (80%), kidney (80%), bone 
marrow (80%), and spleen (78%); tissues least consistent-
ly positive for WNV antigen were heart (50%) and brain 
(10%) (Table 4). However, in terms of virus load, antigen 
was most abundant in the liver, bone marrow, and spleen. 
Overall, at 4 dpi, organs of birds most positive and most 
abundant for viral antigen were those infected by strains 
578/10 and Greece-10, followed by NY99 and Ita09. The 
organs of FIN-infected birds were all negative for virus an-
tigen at this time point.
Discussion
In this study, we assessed the susceptibility of carrion 
crows to different strains of WNV. First we demonstrated 
that carrion crows are susceptible to WNV infection by us-
ing the North American strain NY99, which has previously 
been shown to be highly virulent in American crows (19–
23). In agreement with the findings in those studies, our 
results showed that infection of carrion crows with NY99 
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Figure 1. Survival rate for West Nile virus (WNV)–infected carrion 
crows after inoculation with 2,000 50% tissue culture infectious 
doses of WNV; each group (n = 6) was inoculated with a different 
strain. Crows were monitored daily for signs of disease through 
postinoculation day 14.
 
 
 
Table 3. Clinical profile of American crows experimentally infected with West Nile virus strains NY99-4132, Italy/2009/FIN, and Ita09 
Virus group No. died/no. total (%) 
Median peak viremia, viral RNA/mL 
serum (range); no. birds 
Median peak viremia, TCID50/mL 
serum (range); no. birds* 
NY99-4132 6/6 (100) 109.6 (109.1–1010.1); 6 107.2 (104.7–107.2); 6 
Italy/2009/FIN 0/5 (0) 101.0 (101.0–106.9); 5 101.8 (101.8–102.7); 5 
Ita09 5/5 (100) 108.8 (108.0–109.1); 5 106.7 (106.0–107.5); 5 
*Virus titers are expressed as log10 50% tissue culture infectious dose (TCID50)/mL of serum. 
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resulted in high viremia titers and death. In addition, virus 
had disseminated to the organs of infected birds by 4 dpi, 
further demonstrating the susceptibility of carrion crows to 
WNV infection, which appears to be very similar to that of 
American crows.
Next we studied the susceptibility of carrion crows 
to selected strains of WNV from Europe. We found that 
carrion crows are highly susceptible to infection with both 
lineage 1 and 2 WNV strains from Europe. In addition, 
we showed that susceptibility is strain-dependent. Of the 
5 WNV strains tested, 4 led to death for 83%–100% of in-
fected birds and to high viremia titers and abundant antigen 
in the organs of euthanized birds; however, birds inoculated 
with FIN did not die from infection, and they had relatively 
low virus titers in the blood and no viral antigen in the or-
gans at 4 dpi. A previous study describing the inoculation 
of carrion crows with WNV strains from France (Fr2000) 
and Israel (Is98) also suggested that carrion crows are sus-
ceptible to infection with WNV in a strain-dependent man-
ner (29). The study showed death rates of 33% (Fr2000) 
and 100% (Is98) from the 2 strains, and viral RNA loads 
in serum, oral swab samples, and feathers of Is98-infected 
birds were higher than those of Fr2000-infected birds (29). 
Thus, WNV strains FIN and Fr2000 show a similar attenu-
ation in carrion crows.
To more accurately assess the virulence of WNV 
strains from Europe, we inoculated American crows, a bird 
species known to be highly susceptible to WNV, with 2 of 
the 4 strains from Europe (Ita09 and FIN) and with strain 
NY99 from North America. Similar to what was seen with 
carrion crows, American crows infected with Ita09 had 
high peak viremia titers, and all succumbed to the infec-
tion, whereas those infected with FIN had low viremia ti-
ters, and all survived infection. Furthermore, it was demon-
strated that the Greece-10 strain used in this study was also 
100% lethal in American crows (A.C. Brault et al., unpub. 
data). In fact, American crows infected with Greece-10 (vs. 
the other strains used in this study) had the highest median 
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Figure 2. Viral RNA copy numbers for West Nile virus  
(WNV)–infected carrion crows after inoculation with 2,000 50% 
tissue culture infectious doses of WNV; each group (n = 6) 
was inoculated with a different strain. RNA copy numbers are 
represented as log-transformed medians. The assay had a 
detection limit of 9 (1.0 log10) RNA copies/mL of serum.
Figure 3. Infectious virus titer profiles for West Nile virus 
(WNV)–infected carrion crows after inoculation with 2,000 50% 
tissue culture infectious doses (TCID50) of WNV; each group (n 
= 6) was inoculated with a different strain. Infectious virus titers 
were determined by TCID50 titration and are represented as log-
transformed medians; error bars indicate range. The assay had a 
detection limit of 1.8 TCID50/mL.
Figure 4. Viral RNA copy 
numbers in organs from 10 
carrion crows (2 per group) 
euthanized 4 days after being 
experimentally infected with 1 
of 5 different West Nile virus 
strains (n = 6, per group). Virus 
titers are represented as log-
transformed medians; error bars 
indicate range. The assay had 
a detection limit of 9 (1.0 log10) 
RNA copies/g of tissue. H, heart; 
L, liver; S, spleen; K, kidney; Bo, 
bone marrow; Br, brain.
RESEARCH
peak viremia titers in terms of RNA and infectious virus 
(data not shown). These results show that in American 
crows, WNV strains (apart from FIN) from Europe are as 
virulent as the prototypic NY99 strain from North America.
The fact that susceptibility of birds to WNV can be 
strain-dependent was clearly demonstrated by the attenu-
ated virulence phenotype of WNV strain FIN in carrion 
and American crows (this study) and in European jackdaws 
(30); FIN-infected crows consistently exhibited an absence 
of death, lower peak viremia titers, and less dissemination 
of virus to the organs at the approximate peak of viremia. 
A previous study showed that the introduction of a P249T 
amino acid substitution in the NS3 helicase of North Amer-
ican strain NY99 led to a highly attenuated phenotype, 
whereas a T249P substitution introduced in a low-viru-
lence WNV strain resulted in a phenotype highly virulent 
to American crows (22). Four virus strains used in this 
study contain a proline at NS3-249, whereas FIN contains 
a threonine at this position (31). It is therefore likely that 
the attenuated phenotype of FIN is a result of this threonine 
amino acid at NS3-249, a mutation that could be relevant 
for at least 3 different species of birds in the family Corvi-
dae. Studies in North American and European corvids are 
ongoing in order to test the relevance of the T249P substi-
tution and several other mutations when introduced into the 
genome of WNV-FIN.
We have shown that bird susceptibility to WNV can 
be strain-dependent. However, susceptibility is also clearly 
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Figure 5. Viral RNA copy 
numbers in organs from 22 
carrion crows euthanized 
because of illness after being 
experimentally infected with 1 
of 4 different West Nile virus 
strains (n = 6, per group). Copy 
numbers are represented as log-
transformed medians; error bars 
indicate range. The assay had 
a detection limit of 9 (1.0 log10) 
RNA copies/g of tissue. H, heart; 
L, liver; S, spleen; K, kidney; Bo, 
bone marrow; Br, brain.
 
 
 
Table 4. Immunohistochemical analysis of West Nile virus antigen distribution in experimentally infected carrion crows euthanized  
at 4 dpi* 
Virus strain, bird no. Heart Liver Spleen Kidney 
Bone 
marrow Brain 
Total score 
per bird 
Average 
score per 
virus strain 
No. positive 
organs/total 
no. organs 
NY99-4132        9.0  
 1  ++ ++ + ++  11.0  4/6 
 7  + + +/ +  7.0  4/6 
Nea Santa-Greece-2010        12.5  
 1 +/ ++ ++ + ++ +/ 13.0  6/6 
 7 +/ ++ ++ + ++  12.0  5/6 
Italy/2009/FIN        0  
 1       0  0/6 
 7       0  0/6 
Ita09        8.0  
 1 +/ ++ ++ +/ +  10.0  5/6 
 7  ++ ND +/ +  6.0  3/5 
578/10        12.5  
 1 ++ ++ ++ +/ ++  13.0  5/6 
 7 +/ ++ ++ + ++  12.0  5/6 
Score per organ 7.0 23.0 20.0 12.0 21.0 1.0    
No. positive birds/total no. 
birds 
5/10 8/10 7/9 8/10 8/10 1/10    
*Subjective determinations of the amount of antigen in each organ were made: negative (), minimal (+/), moderate (+), or abundant (++). Each 
determination was given a score from 0 to 3: negative (0), minimal (1), moderate (2), and abundant (3). ND = not determined. dpi, days postinoculation; 
ND, not determined. 
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related to host factors. As a whole, jackdaws were less 
susceptible than the carrion crows to the same selection of 
otherwise highly virulent WNV strains, and they had lower 
death rates and virus loads in blood and organs (30). Spe-
cies susceptibility has been shown to differ within various 
avian families (7), including birds in the family Corvidae, 
of which, for example, the fish crow (Corvus ossifragus) 
was less susceptible to lethal WNV infection (23). Al-
though the reasons for this varied susceptibility are not well 
understood, potential contributing factors may include host 
traits, such as genetic composition, immune response, and 
physiologic mechanisms (23).
A measure of the potential for transmission of virus 
to feeding mosquitoes is the level of infectious virus titers 
produced during viremia. The median peak serum titer of 
infectious virus was highest in Greece-10–infected carrion 
crows and lowest in FIN-infected carrion crows. Studies 
have shown that WNV titers of >105 PFU/mL were con-
sidered infectious for Culex pipiens (32) and Cx. quinque-
fasciatus (33) mosquitoes. Considering this cutoff of 105 
PFU/mL or of 105.2 TCID50/mL, according to a conversion 
factor of 1 TCID50 to 0.7 PFU (34), infectious titers ob-
tained for carrion crows infected with Greece-10, Ita09, 
or NY99 would be sufficient for efficient transmission of 
virus to feeding mosquitoes. Carrion crows infected with 
strain 578/10 had median peak viremia titers slightly be-
low this threshold (105.1 TCID50/mL; Table 2), suggesting 
that the carrion crow may not be an efficient amplifier for 
this WNV strain. However, a possible explanation for the 
apparent low viremia titers in 578/10-infected birds could 
be that blood sampling was conducted on alternate days, 
possibly missing higher peak viremia titers of infectious vi-
rus. For the American crows, median peak viremia titers for 
Ita09 (Table 3) were slightly lower than those for carrion 
crows (Table 2). However, serum samples from American 
crows underwent 2 repeated freeze–thaw cycles, which 
could have resulted in the detection of lower infectious vi-
rus titers. Nonetheless, these results show that WNV strains 
from Europe can produce viremia titers in American crows 
that could be sufficient for efficient transmission to feed-
ing mosquitoes. Nevertheless, reservoir competence stud-
ies involving the feeding of European mosquitoes on vire-
mic WNV-infected carrion crows are needed to determine 
whether the carrion crow could indeed be a potential reser-
voir host and contributor to the WNV transmission cycle. 
We have shown that carrion crows, a species of bird 
ubiquitously found across Europe, are highly susceptible 
to WNV strains currently circulating in Europe. These 
birds could therefore potentially be useful as part of dead 
bird surveillance in the early detection of WNV in Europe. 
Future studies assessing the susceptibility of the closely 
related hooded crow (Corvus cornix) to WNV may also 
prove to be insightful, as this is the more predominant 
corvid species in eastern and southeastern Europe, where 
WNV is more common. The susceptibility of European 
birds to WNV has been demonstrated in multiple studies 
(9,10,12,13,29,30,35–38), however, it is peculiar that the 
number of WNV-associated deaths among birds in Europe 
is not as extensive as that among birds in North America. 
Possible explanations may be a lower reporting of bird 
deaths in Europe as compared with that in the United States 
or that other ecologic factors, such as mosquito compe-
tence, abundance, distribution or behavior, exert a limiting 
effect on the transmission of WNV in Europe.
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